Ubiquitination/ Proteasome


Once the substrate protein is labeled, proteasome will bind to a polyubiquitin chain, allowing the degradation of the labeled protein. The polyubiquitinated target protein is then recognized and degraded by the 26S proteasome. Deubiquitinating enzymes (DUBs) reverse the process of ubiquitination by removing ubiquitin from its substrate protein. Dysregulation of the ubiquitin-proteasome system has been linked to cancer, diabetes, cardiovascular and neurodegenerative diseases etc.
-
B2151 STF-62247Target: AutophagySummary: Autophagy inducer in renal cell -
B1397 Trifluoperazine 2HCl2 CitationSummary: Dopamine D2 receptor inhibitor -
B1395 Sulfacetamide SodiumSummary: Sulfonamide antibiotic -
B1391 Divalproex SodiumSummary: Epilepsy/migraines/bipolar disorder medicine -
A8179 MG-2623 CitationTarget: ProteasomeSummary: Proteasome inhibitor -
B3515 DUBs-IN-2Summary: deubiquitinase enzyme inhibitor -
B3516 DUBs-IN-3Summary: potent deubiquitinase enzyme inhibitor -
B3701 FPH1 (BRD-6125)2 CitationSummary: Hepatocyte functional proliferation enhancer -
B7535 Eeyarestatin ITarget: ERADSummary: inhibitor of endoplasmic reticulum-associated degradation (ERAD) and protein translocation -
B7637 SMER 28Summary: Positive regulator of autophagy

